-+ 0.00%
-+ 0.00%
-+ 0.00%

ABEONA THERAPEUTICS® CONGRATULATES ULTRAGENYX ON U.S. FDA APPROVAL OF FAYUVI™ GENE THERAPY FOR SANFILIPPO SYNDROME TYPE A (MPS IIIA)

Reuters·09/18/2026 11:30:00

Please log in to view news